Insider · CIK 0001974200
Jolanda Howe
officer
Files at MIRM (Mirum Pharmaceuticals, Inc.). First filing Nov 15, 2024, latest Sep 3, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $3.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MIRM: Mirum Pharmaceuticals, Inc.
MIRMOct 9, 2026 · close 86.01
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Mirum Pharmaceuticals, Inc. | $66k 658 shares | -52% | - | |
| 15Weak | Mirum Pharmaceuticals, Inc. | $107k 2,415 shares | -50% | - | |
| 25Weak | Mirum Pharmaceuticals, Inc. | $2.6M 57,606 shares | -603% | - | |
| 12Weak | MIRMsell Mirum Pharmaceuticals, Inc. | $51k 1,064 shares | -20% | - | |
| 11Weak | MIRMsell Mirum Pharmaceuticals, Inc. | $43k 902 shares | -20% | - | |
| 10Weak | MIRMsell Mirum Pharmaceuticals, Inc. | $32k 750 shares | -20% | - | |
| 30Weak | MIRMsell Mirum Pharmaceuticals, Inc. | $118k 2,500 shares | -51% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -658 | $100.00 | $66k | 616 | 39 d ago |
| Mar 18, 2025 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -2,415 | $44.45 | $107k | 2,426 | Mar 19, 2025 |
| Mar 15, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +5,315 | - | - | 9,547 | Mar 18, 2025 |
| Mar 17, 2025 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -2,900 | $44.21 | $128k | 6,647 | Mar 18, 2025 |
| Mar 17, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock10b5-1 | +52,900 | $2.94 | $156k | 59,547 | Mar 18, 2025 |
| Mar 17, 2025 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -50,111 | $44.33 | $2.2M | 9,436 | Mar 18, 2025 |
| Mar 17, 2025 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -2,789 | $44.75 | $125k | 6,647 | Mar 18, 2025 |
| Mar 17, 2025 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -1,806 | $44.36 | $80k | 4,841 | Mar 18, 2025 |
| Mar 15, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Performance Restricted Stock Unitsderivative10b5-1 | -5,315 | $0.00 | $0 | 2,658 | Mar 18, 2025 |
| Mar 17, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -52,900 | $0.00 | $0 | 0 | Mar 18, 2025 |
| Jan 31, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock | +1,772 | - | - | 5,296 | Feb 4, 2025 |
| Feb 3, 2025 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,064 | $48.22 | $51k | 4,232 | Feb 4, 2025 |
| Jan 31, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,772 | $0.00 | $0 | 1,771 | Feb 4, 2025 |
| Jan 23, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock | +1,500 | - | - | 4,426 | Jan 27, 2025 |
| Jan 24, 2025 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -902 | $47.92 | $43k | 3,524 | Jan 27, 2025 |
| Jan 23, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,500 | $0.00 | $0 | 3,000 | Jan 27, 2025 |
| Jan 21, 2025 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +18,500 | $0.00 | $0 | 18,500 | Jan 23, 2025 |
| Jan 21, 2025 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +4,625 | $0.00 | $0 | 4,625 | Jan 23, 2025 |
| Jan 21, 2025 | MIRM Mirum Pharmaceuticals, Inc. | AGrant or award Performance Restricted Stock Unitsderivative | +7,973 | $0.00 | $0 | 7,973 | Jan 23, 2025 |
| Jan 6, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock | +1,250 | - | - | 3,676 | Jan 8, 2025 |
| Jan 7, 2025 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -750 | $42.82 | $32k | 2,926 | Jan 8, 2025 |
| Jan 6, 2025 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -1,250 | $0.00 | $0 | 0 | Jan 8, 2025 |
| Nov 14, 2024 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Common Stock | +2,500 | $2.94 | $7,350 | 4,926 | Nov 15, 2024 |
| Nov 14, 2024 | MIRM Mirum Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -2,500 | $47.10 | $118k | 2,426 | Nov 15, 2024 |
| Nov 14, 2024 | MIRM Mirum Pharmaceuticals, Inc. | MOption exercise Stock Option (right to buy)derivative | -2,500 | $0.00 | $0 | 52,900 | Nov 15, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.